Pediatrix Medical slips; Jefferies downgrades rating

U.S. physician services provider Pediatrix Medical Group MD.N shares fell 2.3% to $25.96 premarket.

Jefferies cut its rating to "hold" from "buy," saying "risk-reward is now more neutral." The brokerage contended that the "eAPTC headwind" is likely to limit near-term earnings growth.

MD reported a rise in Q2 revenue earlier this month.

Six out of seven brokerages rate the stock "hold"; their median PT is $28, according to LSEG data.

Up to the last close, the stock is up 24.2% year to date.